Skip to main content

and
  1. No Access

    Article

    Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study

    Choosing the subcutaneous (SC) route of administration of abatacept and tocilizumab is more cost-effective than the intravenous (IV) route. The objective of this study was to examine patients’ reasons for choo...

    Marie Desplats, Tristan Pascart, Germain Jelin, Laurène Norberciak in Clinical Rheumatology (2017)